SIC
MD icon

SJS Investment Consulting’s Pediatrix Medical MD Stock Holding History

SJS Investment Consulting’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04K Buy
120
+114
+1,900% +$2.59K ﹤0.01% 1607
2026
Q1 		$129 Hold
6
– – ﹤0.01% 2089
2025
Q4 		$129 Buy
+6
New +$123 ﹤0.01% 1909
2024
Q1 		– Sell
-9
Closed -$84 – 1673
2023
Q4 		$84 Sell
9
-3
-25% -$31 ﹤0.01% 1566
2023
Q3 		$153 Sell
12
-4
-25% -$55 ﹤0.01% 1493
2023
Q2 		$228 Buy
16
+1
+7% +$14 ﹤0.01% 1384
2023
Q1 		$224 Hold
15
– – ﹤0.01% 1337
2022
Q4 		$223 Buy
15
+5
+50% +$82 ﹤0.01% 1401
2022
Q3 		$0 Buy
+10
New +$201 ﹤0.01% 1329
2022
Q1 		$0 Buy
+2
New +$49 ﹤0.01% 1092

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

SJS Investment Consulting's MD Position: Q2 2026 in Review

SJS Investment Consulting increased its Pediatrix Medical (MD) stake by 1,900% in Q2 2026, buying an estimated $2.59K and bringing the position to 120 shares worth $3.04K. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

SJS Investment Consulting first reported a position in MD in Q1 2022 and has held it in 10 quarters since. 119 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • SJS Investment Consulting held 120 shares of Pediatrix Medical worth $3.04K as of Q2 2026.
  • SJS Investment Consulting bought 114 Pediatrix Medical shares in Q2 2026, an estimated $2.59K.
  • Pediatrix Medical made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1607 holding.
  • SJS Investment Consulting first reported a position in Pediatrix Medical in Q1 2022 and has held it in 10 quarters since.
  • 119 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.